Inhibition of Constitutively Activated Phosphoinositide 3-Kinase/Akt Pathway Enhances Antitumor Activity of Chemotherapeutic Agents in Breast Cancer Susceptibility Gene 1-Defective Breast Cancer Cells

Molecular Carcinogenesis - United States
doi 10.1002/mc.21905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

AKT2 Oncogene and Phosphoinositide 3-Kinase in Human Breast Cancer

2004English

Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells With Aberrant Akt Activity

Clinical Cancer Research
Cancer ResearchOncology
2004English

Phosphoinositide 3-Kinase Mutations in Breast Cancer: A "Good" Activating Mutation?

Clinical Cancer Research
Cancer ResearchOncology
2009English

Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway Improves Response of Long-Term Estrogen-Deprived Breast Cancer Xenografts to Antiestrogens

Clinical Cancer Research
Cancer ResearchOncology
2007English

Prodigiosin Induces the Proapoptotic Gene NAG-1 via Glycogen Synthase Kinase-3 Activity in Human Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Withaferin a Induces Proteasome-Dependent Degradation of Breast Cancer Susceptibility Gene 1 and Heat Shock Factor 1 Proteins in Breast Cancer Cells

ISRN Biochemistry
2012English

P21-Activated Kinase Signaling in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2004English

Chitosan-Based Nanogel Enhances Chemotherapeutic Efficacy of 10-Hydroxycamptothecin Against Human Breast Cancer Cells

International Journal of Polymer Science
PolymersPlastics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy